An Incisive, In-depth Analysis on the Eubiotics Market
This study offers a comprehensive, 360 degree analysis on the Eubiotics market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Eubiotics market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Global Eubiotics Market to Surpass Reach US$ 12 Bn by 2029
The global eubiotics market is projected to reach US$ 12.4 Bn by the end of 2029. The market was valued at a little above US$ 6 Bn in 2019. If these figures hold true, the market will exhibit a CAGR of 7.5% between 2019 and 2029. Regionally, Europe holds the leading share in the market, in terms of consumption. However during the forecast period, Asia Pacific is expected to demonstrate a higher rate of growth. In terms of type, the market can be classified into probiotics, prebiotics, organic acid, and essential oil. Of these, probiotic dominated the global market in 2019. Rising awareness regarding the benefits of probiotics will support the growth of the segment.
Eubiotics Emerges as a Preferred Alternative to Antibiotics
Antibiotics is banned across several countries in the world. For instance, the use of antibiotics is banned in several developed economies, in turn paving way for the entry of eubiotics producers. Eubiotics is gaining popularity, primarily because they are natural digestive stimulants that help in improving the immune system. As a result of this, eubiotic sales is likely to surge in countries facing antibiotics ban. Excessive coverage has made negative health effects of antibiotics a public concern, compelling governments to ban its usage. This in turn has benefitted the eubiotics market, giving tailwinds to its growth. As a result of this, the demand for different types of eubiotics, including probiotics, prebiotics, essential oil, and organic acid will rise in the coming years. Of these, probiotics is currently leading the global market.
Antibiotics Bans Creates Lucrative Growth Opportunities in Europe
Regionally, the global eubiotics market covers Europe, North America, Latin America, South Asia, East Asia, the MEA, and Oceania. Stringent regulations imposed, banning the use of antibiotics in Europe is a chief growth driver for the eubiotics market in the region. In addition to this, the demand for eubiotics is expected to remain high in Asia Pacific. Growth in this region is propelled by rising demand from countries such as India and China.
Rising Awareness about Health Benefits of Eubiotics will Stoke Growth Opportunities
The rising awareness among consumers about the health benefits of eubiotics will drive market. In addition to this, the market will benefit from their increasing applications in animal feed. A key point to note here is that the rising living standard of people and their increasing disposable income has led to increasing meat consumption. As consumers become more conscious regarding the quality and safety of food, they are more likely to opt for more sustainable alternatives such as eubiotics.
FREQUENTLY ASKED QUESTIONS ABOUT Global Eubiotics Market
What drives the eubiotics market?
The rising demand for healthier alternative for antibiotics is the chief growth driver of the eubiotics market. According to the report by FMI, the demand for eubiotics is expected to surge in response to the rising meat consumption.
Which region will lead the global sales of eubiotics?
Europe currently holds the leading share in eubiotics market. The ban imposed on the use of antibiotics will boost sales of eubiotics in Europe.
Which type segment is witnessing highest demand in eubiotics market?
The demand for probiotics is high among various types of eubiotics available in the market. Probiotics also hold the leading share in the market.
Which segment based on form will record the highest growth?
The demand for solid form of eubiotics is likely to rise at a higher pace over the course of the forecast period.
What are the growth prospects for eubiotics market in emerging nations?
In emerging nations such as India and China, the demand for eubiotics is likely to remain considerably high. The rising living standards and disposable income of consumers have caused a surge in meat consumption in these countries. This in turn creates an environment conducive to the growth of the eubiotics market in emerging nations such as India and China.
Eubiotics: Global Industry Analysis 2014-2018 & Opportunity Assessment 2019-2029
A recent market study published by Future Market Insights on the eubiotics offers global industry analysis for 2014-2018 & opportunity assessment for 2019-2029. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision.
The global Eubiotics is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
Chapter 01 - Executive Summary
The executive summary of the eubiotics includes the market country analysis, proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the global eubiotics.
Chapter 02 – Market Introduction
Readers can find the detailed segmentation and definition of the eubiotics in this chapter, which will help them understand basic information about the eubiotics. This section also highlights the inclusions and exclusions, which help the reader understand the scope of the eubiotics report.
Chapter 03 – Market Background
The associated industry assessment of the eubiotics is carried out in this section. The macroeconomic factors affecting growth of the eubiotics are provided in this section and the impact of these macroeconomic indicators on eubiotics is analyzed. The processing overview and technological advancements in the eubiotics is also provided.
Chapter 04 - Global Eubiotics Market Value Chain
Profit margins at each level of the eubiotics are analyzed and readers can find detailed information on top importers and exporters as well as the value chain of the market.
Chapter 05 – Market Dynamics
The drivers and restraints impacting the growth of the eubiotics are explained in this chapter. Opportunities and ongoing trends in the eubiotics are also comprehensively discussed.
Chapter 06 – Global Eubiotics Analysis and Forecast 2014-2029
This chapter includes detailed analysis of the historical eubiotics (2014-2018), along with an opportunity analysis for the forecast period (2019-2029). Readers can also find the absolute $ opportunity for the current year (2019 - 2020) and incremental opportunity for the forecast period (2019-2029). This chapter provides details about the eubiotics on the basis of by form, by type, by function, by livestock. In this chapter, readers can understand market attractive analysis for all segments. This chapter explains how the eubiotics is anticipated to grow across North America, Latin America, Europe, South Asia, Oceania, East Asia and Middle East and Africa.
Chapter 07 – North America Eubiotics Analysis 2014-2018 & Forecast 2019-2029
This chapter includes a detailed analysis of the growth of the eubiotics in the North America region, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on product type and countries in the North America region.
Chapter 08 – Latin America Eubiotics Analysis 2014-2018 & Forecast 2019-2029
Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of eubiotics in the Latin America region. This chapter also includes growth prospects of the eubiotics in leading LATAM countries such as Brazil, Mexico, and the Rest of Latin America.
Chapter 09 –Europe Eubiotics Analysis 2014-2018 & Forecast 2019-2029
Important growth prospects of the eubiotics based on its end user in several countries such as Germany, Italy, France, U.K., Spain, BENLUX, Russia and Rest of Europe are included in this chapter.
Chapter 10 – South Asia Eubiotics Analysis 2014-2018 & Forecast 2019-2029
This chapter includes a detailed analysis of the growth of the eubiotics in South Asia region including the important growth prospects of the Eubiotics in several countries such as India, Thailand, Indonesia, Malaysia, and Oceania and Rest of South Africa are included in this chapter.
Chapter 11 – East Asia Eubiotics Analysis 2014-2018 & Forecast 2019-2029
This chapter includes a detailed analysis of the growth of the eubiotics in East Asia region including the important growth prospects of the eubiotics in several countries such as China, Japan and South Korea are included in this chapter
Chapter 12 – Oceania Eubiotics Analysis 2014-2018 & Forecast 2019-2029
This chapter includes a detailed analysis of the growth of the eubiotics in the Oceania. Readers can also find regional trends, regulations, and market growth of countries in the Oceania
Chapter 13 – Middle East and Africa Eubiotics Analysis 2014-2018 & Forecast 2019-2029
This chapter offers insights into how the eubiotics is expected to grow in major countries in the MEA region such as GCC Countries, Turkey, South Africa, Northern Africa and the Rest of MEA, during the forecast period 2019-2029.
Chapter 15– Competition Assessment
In this chapter, readers can find detailed information about tier analysis and market concentration of the key players in the eubiotics along with their market presence analysis by region and product portfolio. Readers can find a comprehensive list of leading manufacturers in the eubiotics, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players and end users featured in the report Cargill, BASF SE, E.I. Dupont De Nemours and Company, Koninklijke DSM N.V., Chr. Hansen Holding A/S, Novozymes, Calpis Co., Ltd., Lesaffre Group, Kemin Industries, Inc., Lallemand, Inc., Addcon, Behn Meyer Group, Novus International, Inc., Advanced Bio Nutrition Corp, Beneo Group and others
Chapter 16 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the eubiotics report.
Chapter 17 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on the eubiotics .
Sources and Primary Research Splits (%)